The global demand for Antimicrobial Resistance Market is presumed to reach the market size of nearly USD 10.83 BN by 2030 from USD 5.6 BN in 2022 with a CAGR of 8.6% under the study period 2023 - 2030.
Antimicrobial resistance pertains to the capacity of microorganisms, such as bacteria, viruses, fungi, and parasites, to withstand the impact of antimicrobial medications. These drugs, including antibiotics, antivirals, antifungals, and antiparasitic medications, are used to treat infections in humans, animals, and plants.
The global effort to address antimicrobial resistance (AMR) is driven by a confluence of factors aimed at mitigating this critical health challenge. Growing awareness about the severe consequences of AMR has catalyzed initiatives worldwide. Governments are playing a pivotal role by implementing national action plans, regulatory measures, and funding to combat resistance. Global collaborations and partnerships are essential to address the cross-border nature of AMR, fostering joint initiatives and information sharing. The pressing need for new antimicrobial drugs has led to increased research and development efforts, supported by incentives and collaborations involving the pharmaceutical industry, academia, and governments. Antimicrobial stewardship programs in healthcare settings promote responsible use, while advances in point-of-care diagnostics enable more targeted treatment. Educational campaigns emphasize the importance of responsible antimicrobial use among healthcare professionals and the general public. The extension of efforts to veterinary practices underscores the comprehensive approach required. Incentives for drug development, including grants and regulatory pathways, aim to overcome economic challenges in bringing new antibiotics to market. The collective global response involves diverse stakeholders working together to preserve the efficacy of existing antimicrobials and address the evolving challenge of AMR.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antimicrobial resistance. The growth and trends of antimicrobial resistance industry provide a holistic approach to this study.
This section of the antimicrobial resistance market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Indication
By Drug Class
By Mechanism of Action
By Pathogen
This section covers the regional outlook, which accentuates current and future demand for the Antimicrobial Resistance market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antimicrobial Resistance market include Alkem Laboratories Ltd, Innoviva Inc., Pfizer Inc., Merck & Co. Inc., Acurx Pharmaceuticals Inc., Basilea Pharmaceutica Ltd, Cumberland Pharmaceuticals Inc., Wockhardt Limited, Paratek Pharmaceuticals, Inc. and Nabriva Therapeutics plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . ANTIMICROBIAL RESISTANCE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Indication
3.7.2 Market Attractiveness Analysis By Drug Class
3.7.3 Market Attractiveness Analysis By Mechanism Of Action
3.7.4 Market Attractiveness Analysis By Pathogen
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL ANTIMICROBIAL RESISTANCE MARKET ANALYSIS BY INDICATION
5.1 Overview by Indication
5.2 Historical and Forecast Data
5.3 Analysis by Indication
5.4 Complicated Urinary Tract Infections (cUTI) Historic and Forecast Sales by Regions
5.5 Blood Stream Infections Historic and Forecast Sales by Regions
5.6 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Historic and Forecast Sales by Regions
5.7 Hospital Acquired Bacterial Pneumonia And Ventilator Acquired Bacterial Pneumonia (HABP and VABP) Historic and Forecast Sales by Regions
5.8 Community Acquired Pneumonia (CAP) Historic and Forecast Sales by Regions
5.9 Others Historic and Forecast Sales by Regions